|
Drug Therapy, Other
Citations 301-310 of 395 total displayed.
|
Past content
(since Mar 1999):
|
- Original Investigations
Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation
- Cheryl Oncken; David Gonzales; Mitchell Nides; Stephen Rennard; Eric Watsky; Clare B. Billing; Richard Anziano; Karen Reeves; for the Varenicline Study Group
Arch Intern Med 2006; 166: 1571-1577.
[Abstract]
[Full text]
[PDF]
- Editor's Correspondence
From Chaotic to Coordinated Clinical Research: The Case of Acetylcysteine
- Giuseppe G. L. Biondi-Zoccai; Antonio Abbate; Marco Valgimigli; Luca Testa; Pierfrancesco Agostoni
Arch Intern Med 2006; 166: 1668.
[Extract]
[Full text]
[PDF]
- Commentaries
"Therapeutic Intent" in Phase 1 Oncology Trials: A Justifiable Objective
- Maurie Markman
Arch Intern Med 2006; 166: 1446-1448.
[Extract]
[Full text]
[PDF]
- Original Investigations
Stimulation With 0.3-mg Recombinant Human Thyrotropin Prior to Iodine 131 Therapy to Improve the Size Reduction of Benign Nontoxic Nodular Goiter: A Prospective Randomized Double-blind Trial
- Viveque Egsgaard Nielsen; Steen Joop Bonnema; Henrik Boel-Jørgensen; Peter Grupe; Laszlo Hegedüs
Arch Intern Med 2006; 166: 1476-1482.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Evaluation and Treatment of Pharyngitis in Primary Care Practice: The Difference Between Guidelines Is Largely Academic
- Jeffrey A. Linder; Joseph C. Chan; David W. Bates
Arch Intern Med 2006; 166: 1374-1379.
[Abstract]
[Full text]
[PDF]
- Editor's Correspondence
Etanercept or Infliximab: The Patient’s Considerations—Reply
- Esi Morgan DeWitt; Henry A. Glick; Daniel A. Albert; Frederick Wolfe
Arch Intern Med 2006; 166: 1418-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Etanercept or Infliximab: The Patient’s Considerations
- Robert C. Sherrick
Arch Intern Med 2006; 166: 1418.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Mechanism of Action of Ranolazine
- Celeste Marx; Michael Sweeney
Arch Intern Med 2006; 166: 1325-a-1326-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Mechanism of Action of Ranolazine—Reply
- David Nash
Arch Intern Med 2006; 166: 1326.
[Extract]
[Full text]
[PDF]
- Original Investigations
The Cost-effectiveness of Therapy With Teriparatide and Alendronate in Women With Severe Osteoporosis
- Hau Liu; Kaleb Michaud; Smita Nayak; David B. Karpf; Douglas K. Owens; Alan M. Garber
Arch Intern Med 2006; 166: 1209-1217.
[Abstract]
[Full text]
[PDF]
|
|
